COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
Swathi Beladakere Ramaswamy, Raghav Govindarajan
Abstract
This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.
Topics & Concepts
Myasthenia gravisCoronavirus disease 2019 (COVID-19)Refractory (planetary science)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Outcome (game theory)PediatricsIntensive care medicineVirologyInternal medicineDiseaseOutbreakAstrobiologyInfectious disease (medical specialty)PhysicsMathematical economicsMathematicsMyasthenia Gravis and ThymomaParkinson's Disease and Spinal DisordersPeripheral Neuropathies and Disorders